2020
Clinical Etiologies, Microbial Spectrum, Antibiotic Susceptibilities, and Visual Acuity Outcomes of Acute Endophthalmitis
Lu LJ, Chen X, Adelman RA. Clinical Etiologies, Microbial Spectrum, Antibiotic Susceptibilities, and Visual Acuity Outcomes of Acute Endophthalmitis. Journal Of Ocular Pharmacology And Therapeutics 2020, 36: 534-539. PMID: 32609038, DOI: 10.1089/jop.2018.0074.Peer-Reviewed Original ResearchConceptsVisual acuity outcomesClinical etiologyAntibiotic susceptibilityMicrobial spectrumAcute endophthalmitisAcuity outcomesPostoperative infectionCorneal ulcersCataract extractionEtiology of endophthalmitisFinal VA outcomesTertiary referral centerMajority of patientsRetrospective chart reviewICD-10 codesSpectrum of pathogensCommon inciting factorCulture-proven endophthalmitisChart reviewReferral centerVisual outcomeVA outcomesExogenous endophthalmitisClinical recordsMedical records
2012
Microbial Spectrum and Resistance Patterns in Endophthalmitis: A 21-Year (1988–2008) Review in Northeast United States
Chen X, Adelman RA. Microbial Spectrum and Resistance Patterns in Endophthalmitis: A 21-Year (1988–2008) Review in Northeast United States. Journal Of Ocular Pharmacology And Therapeutics 2012, 28: 329-334. PMID: 22506856, DOI: 10.1089/jop.2011.0204.Peer-Reviewed Original Research
2008
Trends in Resistance to Ciprofloxacin, Cefazolin, and Gentamicin in the Treatment of Bacterial Keratitis
Afshari NA, K. J, Duncan SM, Pineda R, Starr CE, DeCroos FC, Johnson CS, Adelman RA. Trends in Resistance to Ciprofloxacin, Cefazolin, and Gentamicin in the Treatment of Bacterial Keratitis. Journal Of Ocular Pharmacology And Therapeutics 2008, 24: 217-223. PMID: 18331204, DOI: 10.1089/jop.2007.0085.Peer-Reviewed Original Research